ZK824859 is primarily investigated for its potential therapeutic applications in the field of oncology. It has shown promise as a targeted agent in cancer treatment, particularly in inhibiting specific pathways that contribute to tumor growth and survival. Research suggests it may be effective in disrupting cellular mechanisms that allow cancer cells to proliferate, making it a candidate for further development in precision medicine. Additionally, its role in modulating key molecular targets could offer benefits in reducing resistance to conventional therapies, potentially improving outcomes for patients with difficult-to-treat cancers. Ongoing studies are exploring its efficacy and safety in preclinical and clinical settings.